We are monitoring the impact of COVID-19 on Europe Antacid Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2267
Share on
Share on

Europe Antacid Market Research Report - Segmented By Drug Class, Formulation Type, Distribution Channel and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2267
Pages: 145

Europe Antacid Market Size (2021 to 2026)

The size of the Europe Antacid Market value was worth USD 4.16 billion in 2021. It is further estimated to be growing at a CAGR of 4.3% and value USD 5.14 billion by 2026.

Antacids are a group of medications that help neutralize the content of acid reflux in the stomach. It provides fast relief of heartburn, one of the main symptoms of gastroesophageal reflux digestion, and other symptoms are nausea, bloating, or belching. Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids incorporate magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. A few people have announced unfavorably susceptible responses to antacids.

The growing trend toward self-medication is increasing the demand for over-the-counter digestive products to treat gastrointestinal disorders. Antacids are used to neutralize acidity and should therefore cause a dramatic increase in demand. According to a study conducted by the American Gastroenterological Association and published in the International Functional Foundation in February 2017, about one-third of the US population. Suffering from GERD. Market restraints include some side effects such as constipation, laxative effect, and allergic reactions. Also, people suffering from certain medical conditions are prone to adverse effects that worsen their state of health because people with heart disease may have problems due to the high amount of sodium present in antacids.

This research report on the Europe Antacid Market segmented and sub-segmented into the following categories and evaluated market size and forecast until 2025:

By Drug Class: 

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-motility Agents

By Formulation Type: 

  • Tablet
  • Liquid
  • Powder

By Distribution Channel: 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Country: 

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

The market is segmented into the UK, Spain, Germany, France, and others by geography. It is occupying last second place in terms of market share. Among them, the UK and Germany have occupied the highest share. German has many investments compared to other regions.

Some of the Prominent Companies leading the European Antacid Market profiled in this report are GlaxoSmithKline plc, Abbott Laboratories, Pfizer, Inc., Sun Pharma, Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Submarkets                

                                5.1.1 Introduction           

                                5.1.2 Chromatography  

                                5.1.3 E-Clinical Trial Solutions      

                                5.1.4 Wireless Health, Clinical Trial Management Systems(CTMS)              

                                5.1.5 Healthcare IT outsourcing 

                                5.1.6 Immunoassay        

                                5.1.7 Digital Pathology   

                                5.1.8 Next Generation sequencing(NGS)             

                                5.1.9 Proteomics             

                                5.1.10 Magnesium Compounds

                                5.1.11 , Aluminium Compounds

                                5.1.12 Calcium Compounds         

                                5.1.13 Antacids with Antiflatulents          

                                5.1.14  Y-o-Y Growth Analysis, By Submarkets    

                                5.1.15  Market Attractiveness Analysis, By Submarkets  

                                5.1.16  Market Share Analysis, By Submarkets   

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Novel Dietary Fibers           

                                5.2.3 Y-o-Y Growth Analysis, By Application         

                                5.2.4  Market Attractiveness Analysis, By Application      

                                5.2.5  Market Share Analysis, By Application       

                5.3 Ingredients                 

                                5.3.1 Introduction           

                                5.3.2 Protease  

                                5.3.3 Modified Starch    

                                5.3.4 Food & Beverage Starch    

                                5.3.5 Gellatin     

                                5.3.6 Collagen   

                                5.3.7 Carbohydrase        

                                5.3.8 Food & Beverage Sugars & its substitutes 

                                5.3.9 Y-o-Y Growth Analysis, By Ingredients        

                                5.3.10  Market Attractiveness Analysis, By Ingredients   

                                5.3.11  Market Share Analysis, By Ingredients    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Submarkets

                                                6.1.3.3 By Application

                                                6.1.3.5 By Ingredients

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Submarkets

                                                6.1.4.3 By Application

                                                6.1.4.4 By Ingredients

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Submarkets

                                                6.1.5.3 By Application

                                                6.1.5.4 By Ingredients

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 First Aid Only                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GSK                

                8.3 WellSpring Pharm                    

                8.4 Private Lable                              

                8.5 Pfizer                            

                8.6 Procter & Gamble                    

                8.7 Glaxosmithkline                       

                8.8 Boehringer Ingellheim Pharm                             

                8.9 Novaritis Consurmer Health                

                8.10 Johnson & Johnson                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Antacid Market, By Submarkets, From 2021 to 2026 (USD Million)
  2. Europe Chromatography Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe E-Clinical Trial Solutions Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Wireless Health Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Clinical Trial Management System (CTMS) Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe Healthcare IT Outsourcing Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Immunoassay Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Digital Pathology Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Next Generation Sequencing(NGS) Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Antacids with Antiflatulents Market, By Region, From 2021 to 2026 (USD Million)
  12. Europe Antacid Market, By Application, From 2021 to 2026 (USD Million)
  13. Europe Novel Dietary Fibers Market, By Region, From 2021 to 2026 (USD Million)
  14. Europe Antacid Market, By Ingredients, From 2021 to 2026 (USD Million)
  15. Europe Protease Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Modified  Starch Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Food & Beverage Starch Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe Gelatin Market, By Region, From 2021 to 2026 (USD Million)
  19. Europe Collagen Market, By Region, From 2021 to 2026 (USD Million)
  20. Europe Carbohydrase Market, By Region, From 2021 to 2026 (USD Million)
  21. Europe Food & Beverage Sugars & its subtitutes Market, By Region, From 2021 to 2026 (USD Million)
  22. U.K. Antacid Market, By Submarkets, From 2021 to 2026 (USD Million)
  23. U.K. Antacid Market, By Application, From 2021 to 2026 (USD Million)
  24. U.K. Antacid Market, By Ingredients, From 2021 to 2026 (USD Million)
  25. Germany Antacid Market, By Submarkets, From 2021 to 2026 (USD Million)
  26. Germany Antacid Market, By Application, From 2021 to 2026 (USD Million)
  27. Germany Antacid Market, By Ingredients, From 2021 to 2026 (USD Million)
  28. France Antacid Market, By Submarkets, From 2021 to 2026 (USD Million)
  29. France Antacid Market, By Application, From 2021 to 2026 (USD Million)
  30. France Antacid Market, By Ingredients, From 2021 to 2026 (USD Million)
  31. Italy Antacid Market, By Submarkets, From 2021 to 2026 (USD Million)
  32. Italy Antacid Market, By Application, From 2021 to 2026 (USD Million)
  33. Italy Antacid Market, By Ingredients, From 2021 to 2026 (USD Million)
  34. Spain Antacid Market, By Submarkets, From 2021 to 2026 (USD Million)
  35. Spain Antacid Market, By Application, From 2021 to 2026 (USD Million)
  36. Spain Antacid Market, By Ingredients, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample